Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Transforming Radiology with Artificial Intelligence to Fight Abdominal Cancer

Project description

AI-based radiology for abdominal cancer diagnosis

Abdominal malignant tumours are among the most prevalent and fatal cancers. Pancreatic cancer, in particular, is the fourth leading cause of cancer deaths in Europe and has the lowest five-year survival rate among common cancers. The EU-funded TRAIFAC project will showcase an artificial intelligence tool developed by Sycai Technologies (SYCAI) to help radiologists detect and classify abdominal lesions through imaging. This tool is designed to outperform traditional methods in accuracy and can prevent lesions from progressing to pancreatic cancer. By integrating this ‘0-click’ assistant into their workflow, radiologists will have quick access to critical information, reducing the need for invasive tests and surgery. The company aims to offer early-stage diagnosis of abdominal cancers using non-invasive tools.

Objective

Abdominal malignant tumours represent one of the groups of oncological pathologies with the highest prevalence and mortality. Annually, new cancer cases related to organs in the abdomen (pancreas, liver, kidney, etc.) are diagnosed globally, representing more than 1.4 million annual deaths worldwide. Particularly, pancreatic cancer is the fourth cause of death by cancer in Europe, but it has the lowest 5-year survival rate among the common cancers.
Sycai Technologies S.L. (SYCAI) is a deep-tech company that has developed an Artificial Intelligence digital tool to assist radiologists to detect and classify abdominal lesions through imaging. Currently, our tool prevents the abdominal lesions from progressing to pancreatic cancer with an accuracy superior to the standard identification procedures.
By integrating this assistant in the workflow of radiologists with our “0-clicks” approach, the information will be easily accessible by professionals to accelerate the identification of precursor lesions, avoiding invasive tests, surgeries, and patient complications.
At SYCAI we have the vision to provide non-invasive tools to assist in the early-stage diagnosis of any type of abdominal cancer. We aim to impact our society positively, contributing to improving the quality of life of patients with abdominal lesions with a low probability of evolving towards malignant lesions. Additionally, our solutions will improve the dedication of resources to patients needing prioritisation in cancer care according to the status of lesions. Therefore, SYCAI contributes to public expenditure savings for a sustainable and resilient European healthcare system.
Sara Toledano, CEO and Julia Rodríguez, CSO, apply to the Women TechEU programme since they are eager to improve their leadership skills to face the challenge of market entrance in Europe and to be prepared for sales, operations and team growth.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-CSA - HORIZON Coordination and Support Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIE-2022-SCALEUP-02

See all projects funded under this call

Coordinator

SYCAI TECHNOLOGIES SL
Net EU contribution
€ 75 000,00
Address
CARRER VILADOMAT 226, 1-3
08029 Barcelona
Spain
Region
Este Cataluña Barcelona
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
No data